wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q50116255-0B465ECD-4552-40AA-ACA7-6AC5395C0652
Q50116255-0B465ECD-4552-40AA-ACA7-6AC5395C0652
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50116255-0B465ECD-4552-40AA-ACA7-6AC5395C0652
Talimogene Laherparepvec: First in Class Oncolytic Virotherapy.
P2860
Q50116255-0B465ECD-4552-40AA-ACA7-6AC5395C0652
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50116255-0B465ECD-4552-40AA-ACA7-6AC5395C0652
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b04ba680bd1fa30c74982cddf16478f7a578bdbd
P2860
Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma.